Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis

Adenosine-to-inosine RNA editing, which is catalyzed by adenosine deaminases acting on RNA (ADAR) family of enzymes, ADAR1 and ADAR2, has been shown to contribute to multiple cancers. However, other than the chronic myeloid leukemia blast crisis, relatively little is known about its role in other ty...

Full description

Bibliographic Details
Main Authors: Guo, Mingrui, Chan, Tim Hon Man, Zhou, Qiling, An, Omer, Li, Ying, Song, Yangyang, Tan, Zi Hui, Ng, Vanessa Hui En, Peramangalam, Philomina Sona, Tan, Zhi Qing, Cao, Xinang, Iwanaga, Eisaku, Matsuoka, Masao, Ooi, Melissa G. M., Jen, Wei Ying, Koh, Liang Piu, Chan, Esther, Tan, Lip Kun, Goh, Yufen, Wang, Wilson, Koh, Bryan T. H., Chun, Chan Ming, Fullwood, Melissa Jane, Chng, Wee Joo, Osato, Motomi, Pulikkan, John Anto, Yang, Henry, Chen, Leilei, Tenen, Daniel G.
Other Authors: School of Biological Sciences
Format: Journal Article
Language:English
Published: 2023
Subjects:
Online Access:https://hdl.handle.net/10356/170596
_version_ 1811679297168998400
author Guo, Mingrui
Chan, Tim Hon Man
Zhou, Qiling
An, Omer
Li, Ying
Song, Yangyang
Tan, Zi Hui
Ng, Vanessa Hui En
Peramangalam, Philomina Sona
Tan, Zhi Qing
Cao, Xinang
Iwanaga, Eisaku
Matsuoka, Masao
Ooi, Melissa G. M.
Jen, Wei Ying
Koh, Liang Piu
Chan, Esther
Tan, Lip Kun
Goh, Yufen
Wang, Wilson
Koh, Bryan T. H.
Chun, Chan Ming
Fullwood, Melissa Jane
Chng, Wee Joo
Osato, Motomi
Pulikkan, John Anto
Yang, Henry
Chen, Leilei
Tenen, Daniel G.
author2 School of Biological Sciences
author_facet School of Biological Sciences
Guo, Mingrui
Chan, Tim Hon Man
Zhou, Qiling
An, Omer
Li, Ying
Song, Yangyang
Tan, Zi Hui
Ng, Vanessa Hui En
Peramangalam, Philomina Sona
Tan, Zhi Qing
Cao, Xinang
Iwanaga, Eisaku
Matsuoka, Masao
Ooi, Melissa G. M.
Jen, Wei Ying
Koh, Liang Piu
Chan, Esther
Tan, Lip Kun
Goh, Yufen
Wang, Wilson
Koh, Bryan T. H.
Chun, Chan Ming
Fullwood, Melissa Jane
Chng, Wee Joo
Osato, Motomi
Pulikkan, John Anto
Yang, Henry
Chen, Leilei
Tenen, Daniel G.
author_sort Guo, Mingrui
collection NTU
description Adenosine-to-inosine RNA editing, which is catalyzed by adenosine deaminases acting on RNA (ADAR) family of enzymes, ADAR1 and ADAR2, has been shown to contribute to multiple cancers. However, other than the chronic myeloid leukemia blast crisis, relatively little is known about its role in other types of hematological malignancies. Here, we found that ADAR2, but not ADAR1 and ADAR3, was specifically downregulated in the core-binding factor (CBF) acute myeloid leukemia (AML) with t(8;21) or inv(16) translocations. In t(8;21) AML, RUNX1-driven transcription of ADAR2 was repressed by the RUNX1-ETO additional exon 9a fusion protein in a dominant-negative manner. Further functional studies confirmed that ADAR2 could suppress leukemogenesis specifically in t(8;21) and inv16 AML cells dependent on its RNA editing capability. Expression of 2 exemplary ADAR2-regulated RNA editing targets coatomer subunit α and component of oligomeric Golgi complex 3 inhibits the clonogenic growth of human t(8;21) AML cells. Our findings support a hitherto, unappreciated mechanism leading to ADAR2 dysregulation in CBF AML and highlight the functional relevance of loss of ADAR2-mediated RNA editing to CBF AML.
first_indexed 2024-10-01T03:06:55Z
format Journal Article
id ntu-10356/170596
institution Nanyang Technological University
language English
last_indexed 2024-10-01T03:06:55Z
publishDate 2023
record_format dspace
spelling ntu-10356/1705962023-09-25T15:31:54Z Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis Guo, Mingrui Chan, Tim Hon Man Zhou, Qiling An, Omer Li, Ying Song, Yangyang Tan, Zi Hui Ng, Vanessa Hui En Peramangalam, Philomina Sona Tan, Zhi Qing Cao, Xinang Iwanaga, Eisaku Matsuoka, Masao Ooi, Melissa G. M. Jen, Wei Ying Koh, Liang Piu Chan, Esther Tan, Lip Kun Goh, Yufen Wang, Wilson Koh, Bryan T. H. Chun, Chan Ming Fullwood, Melissa Jane Chng, Wee Joo Osato, Motomi Pulikkan, John Anto Yang, Henry Chen, Leilei Tenen, Daniel G. School of Biological Sciences Cancer Science Institute of Singapore Institute of Molecular and Cell Biology, A*STAR Science::Medicine Science::Biological sciences Acute Myeloid Leukemia Core Binding Factor Adenosine-to-inosine RNA editing, which is catalyzed by adenosine deaminases acting on RNA (ADAR) family of enzymes, ADAR1 and ADAR2, has been shown to contribute to multiple cancers. However, other than the chronic myeloid leukemia blast crisis, relatively little is known about its role in other types of hematological malignancies. Here, we found that ADAR2, but not ADAR1 and ADAR3, was specifically downregulated in the core-binding factor (CBF) acute myeloid leukemia (AML) with t(8;21) or inv(16) translocations. In t(8;21) AML, RUNX1-driven transcription of ADAR2 was repressed by the RUNX1-ETO additional exon 9a fusion protein in a dominant-negative manner. Further functional studies confirmed that ADAR2 could suppress leukemogenesis specifically in t(8;21) and inv16 AML cells dependent on its RNA editing capability. Expression of 2 exemplary ADAR2-regulated RNA editing targets coatomer subunit α and component of oligomeric Golgi complex 3 inhibits the clonogenic growth of human t(8;21) AML cells. Our findings support a hitherto, unappreciated mechanism leading to ADAR2 dysregulation in CBF AML and highlight the functional relevance of loss of ADAR2-mediated RNA editing to CBF AML. Published version This work was supported by the Singapore Ministry of Health’s National Medical Research Council (NMRC), the Singapore National Research Foundation, the Singapore Ministry of Education (MOE) under its Research Centres of Excellence initiative, and the National Institutes of Health with following details: Singapore Translational Research Investigator Award, National Institutes of Health grant (P01 HL131477 (D.G.T.), MOE Tier 2 grants (MOE2019 T2-1-083 and MOE2019 T2-2-008), NMRC Clinician Scientist-Individual Research grants (project IDs: MOH 000214 and MOH-001092-00), and the Health and Biomedical Sciences Industry Alignment Fund Pre-Positioning (H20C6a0034) (L.C.), NMRC Open Fund Young Individual Research grant ( MOH OFYIRG20nov-0011) and MOE Research Scholarship Block grant (N 171 000 019 001) (Q.Z.), as well as MOE Tier 3 grant (MOE2014-T3-1-006) (D.G.T. and L.C.). 2023-09-25T00:57:25Z 2023-09-25T00:57:25Z 2023 Journal Article Guo, M., Chan, T. H. M., Zhou, Q., An, O., Li, Y., Song, Y., Tan, Z. H., Ng, V. H. E., Peramangalam, P. S., Tan, Z. Q., Cao, X., Iwanaga, E., Matsuoka, M., Ooi, M. G. M., Jen, W. Y., Koh, L. P., Chan, E., Tan, L. K., Goh, Y., ...Tenen, D. G. (2023). Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis. Blood, 141(25), 3078-3090. https://dx.doi.org/10.1182/blood.2022015830 0006-4971 https://hdl.handle.net/10356/170596 10.1182/blood.2022015830 36796022 2-s2.0-85160255876 25 141 3078 3090 en Blood © 2023 by The American Society of Hematology. All rights reserved. This paper was published in Blood and is made available with permission of The American Society of Hematology. application/pdf
spellingShingle Science::Medicine
Science::Biological sciences
Acute Myeloid Leukemia
Core Binding Factor
Guo, Mingrui
Chan, Tim Hon Man
Zhou, Qiling
An, Omer
Li, Ying
Song, Yangyang
Tan, Zi Hui
Ng, Vanessa Hui En
Peramangalam, Philomina Sona
Tan, Zhi Qing
Cao, Xinang
Iwanaga, Eisaku
Matsuoka, Masao
Ooi, Melissa G. M.
Jen, Wei Ying
Koh, Liang Piu
Chan, Esther
Tan, Lip Kun
Goh, Yufen
Wang, Wilson
Koh, Bryan T. H.
Chun, Chan Ming
Fullwood, Melissa Jane
Chng, Wee Joo
Osato, Motomi
Pulikkan, John Anto
Yang, Henry
Chen, Leilei
Tenen, Daniel G.
Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis
title Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis
title_full Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis
title_fullStr Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis
title_full_unstemmed Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis
title_short Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis
title_sort core binding factor fusion downregulation of adar2 rna editing contributes to aml leukemogenesis
topic Science::Medicine
Science::Biological sciences
Acute Myeloid Leukemia
Core Binding Factor
url https://hdl.handle.net/10356/170596
work_keys_str_mv AT guomingrui corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT chantimhonman corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT zhouqiling corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT anomer corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT liying corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT songyangyang corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT tanzihui corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT ngvanessahuien corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT peramangalamphilominasona corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT tanzhiqing corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT caoxinang corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT iwanagaeisaku corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT matsuokamasao corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT ooimelissagm corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT jenweiying corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT kohliangpiu corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT chanesther corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT tanlipkun corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT gohyufen corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT wangwilson corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT kohbryanth corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT chunchanming corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT fullwoodmelissajane corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT chngweejoo corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT osatomotomi corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT pulikkanjohnanto corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT yanghenry corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT chenleilei corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis
AT tenendanielg corebindingfactorfusiondownregulationofadar2rnaeditingcontributestoamlleukemogenesis